1
|
Ignatyeva O, Daniel V, Zelenova E, Cherdakli A, Bolashova E, Matkava L, Shegurova A, Volkov M, Zagainova A, Kashtanova D, Ivanov M, Bembeeva B, Zubkov V, Gordeev A, Priputnevich T, Yudin V, Makarov V, Keskinov A, Kraevoy S, Yudin S, Skvortsova V. The "crossover effect" of COVID-19 in pregnancy on the infant microbiome. Front Microbiol 2025; 16:1569279. [PMID: 40438213 PMCID: PMC12117587 DOI: 10.3389/fmicb.2025.1569279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2025] [Accepted: 04/23/2025] [Indexed: 06/01/2025] Open
Abstract
Background The COVID-19 pandemic has had a significant impact on public health. However, the impact of COVID-19 infection during pregnancy on the microbiome of the mother and her newborn child still remains poorly understood. Methods This study involved 94 mother-child pairs whose mothers had COVID-19 during pregnancy and 44 newborns as a control group recruited in 2018. Stool samples were collected from women before delivery and from infants at 5-7 days after birth and used for 16S rRNA sequencing. Results We found that the microbiomes of infants exposed in utero to COVID-19 showed decreased microbial diversity and richness. Moreover, we observed a higher inter-sample variability between infant samples in the case group, which might suggest destabilization of their microbiomes. Neither alpha- nor beta-diversity metrics differed significantly between the groups depending on the trimester when the mother contracted COVID-19. Thus, the timing of prenatal COVID-19 exposure had no effect on the infant gut microbiome. Conclusion COVID-19 during pregnancy can significantly compromise the establishment of the infant gut microbiome presumably by disrupting the mother's microbiome.
Collapse
Affiliation(s)
- O. Ignatyeva
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - V. Daniel
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - E. Zelenova
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - A. Cherdakli
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - E. Bolashova
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - L. Matkava
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - A. Shegurova
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - M. Volkov
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - A. Zagainova
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - D. Kashtanova
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - M. Ivanov
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - B. Bembeeva
- Federal State Budgetary Institution “Kulakov National Medical Research Centre for Obstetrics, Gynecology, and Perinatology”, Ministry of Health of the Russian Federation, Moscow, Russia
| | - V. Zubkov
- Federal State Budgetary Institution “Kulakov National Medical Research Centre for Obstetrics, Gynecology, and Perinatology”, Ministry of Health of the Russian Federation, Moscow, Russia
| | - A. Gordeev
- Federal State Budgetary Institution “Kulakov National Medical Research Centre for Obstetrics, Gynecology, and Perinatology”, Ministry of Health of the Russian Federation, Moscow, Russia
| | - T. Priputnevich
- Federal State Budgetary Institution “Kulakov National Medical Research Centre for Obstetrics, Gynecology, and Perinatology”, Ministry of Health of the Russian Federation, Moscow, Russia
| | - V. Yudin
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - V. Makarov
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - A. Keskinov
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - S. Kraevoy
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | - S. Yudin
- Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Biomedical Agency, Moscow, Russia
| | | |
Collapse
|
2
|
Zhou X, Chen X, Davis MM, Snyder MP. Embracing Interpersonal Variability of Microbiome in Precision Medicine. PHENOMICS (CHAM, SWITZERLAND) 2025; 5:8-13. [PMID: 40313605 PMCID: PMC12040794 DOI: 10.1007/s43657-024-00201-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/13/2024] [Revised: 09/02/2024] [Accepted: 09/04/2024] [Indexed: 05/03/2025]
Affiliation(s)
- Xin Zhou
- Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305 USA
- Stanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA 94305 USA
| | - Xin Chen
- Stanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305 USA
| | - Mark M. Davis
- Stanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305 USA
| | - Michael P. Snyder
- Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305 USA
- Stanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA 94305 USA
| |
Collapse
|
3
|
Si HR, Wu K, Su J, Dong TY, Zhu Y, Li B, Chen Y, Li Y, Shi ZL, Zhou P. Individual virome analysis reveals the general co-infection of mammal-associated viruses with SARS-related coronaviruses in bats. Virol Sin 2024; 39:565-573. [PMID: 38945213 PMCID: PMC11401474 DOI: 10.1016/j.virs.2024.06.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2024] [Accepted: 06/19/2024] [Indexed: 07/02/2024] Open
Abstract
Bats are the natural reservoir hosts for SARS-related coronavirus (SARSr-CoV) and other highly pathogenic microorganisms. Therefore, it is conceivable that an individual bat may harbor multiple microbes. However, there is limited knowledge on the overall co-circulation of microorganisms in bats. Here, we conducted a 16-year monitoring of bat viruses in south and central China and identified 238 SARSr-CoV positive samples across nine bat species from ten provinces or administrative districts. Among these, 76 individual samples were selected for further metagenomics analysis. We found a complex microenvironment characterized by the general co-circulation of microbes from two different sources: mammal-associated viruses or environment-associated microbes. The later includes commensal bacteria, enterobacteria-related phages, and insect or fungal viruses of food origin. Results showed that 25% (19/76) of the samples contained at least one another mammal-associated virus, notably alphacoronaviruses (13/76) such as AlphaCoV/YN2012, HKU2-related CoV and AlphaCoV/Rf-HuB2013, along with viruses from other families. Notably, we observed three viruses co-circulating within a single bat, comprising two coronavirus species and one picornavirus. Our analysis also revealed the potential presence of pathogenic bacteria or fungi in bats. Furthermore, we obtained 25 viral genomes from the 76 bat SARSr-CoV positive samples, some of which formed new evolutionary lineages. Collectively, our study reveals the complex microenvironment of bat microbiome, facilitating deeper investigations into their pathogenic potential and the likelihood of cross-species transmission.
Collapse
Affiliation(s)
- Hao-Rui Si
- Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 43000, China; University of Chinese Academy of Sciences, Beijing 100000, China
| | - Ke Wu
- Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou 510005, China
| | - Jia Su
- Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 43000, China; University of Chinese Academy of Sciences, Beijing 100000, China
| | - Tian-Yi Dong
- Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 43000, China; University of Chinese Academy of Sciences, Beijing 100000, China
| | - Yan Zhu
- Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 43000, China
| | - Bei Li
- Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 43000, China
| | - Ying Chen
- Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 43000, China
| | - Yang Li
- Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 43000, China
| | - Zheng-Li Shi
- Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 43000, China; Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou 510005, China.
| | - Peng Zhou
- Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou 510005, China; State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical School, Guangzhou 510005, China.
| |
Collapse
|